Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12931-015-0249-8
Published Online: 2015-08-18
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
O’Byrne, Paul M.
D’Urzo, Tony
Beck, Ekkehard
Fležar, Matjaž
Gahlemann, Martina
Hart, Lorna
Blahova, Zuzana
Toorawa, Robert
Beeh, Kai-Michael
License valid from 2015-08-18